Results 181 to 190 of about 159,964 (350)

Hypoalbuminemia as a prognostic marker for survival in biliary tract cancer: associations with tumor type, treatment and sex. [PDF]

J Cancer Res Clin Oncol
Abdulrazzak M, Björkhem-Bergman L, Villard C, Gerling M, Gustavell T, Jansson H.   +5 more
europepmc   +1 more source

Pharmacological Inhibition of APT2 by Solasonine Promotes Ferroptosis Through Palmitoylation Modulation in Gallbladder Cancer

Phytotherapy Research, EarlyView.
Schematic illustration of SS‐induced ferroptosis through targeting APT2‐mediated STAT3 palmitoylation in GBC cells. ABSTRACT Gallbladder cancer (GBC), the most prevalent and lethal biliary tract malignancy, lacks effective therapeutic strategies. Solasonine (SS), a bioactive steroidal alkaloid derived from Solanum nigrum L, exhibits antitumor activity ...
Liu‐qing Shi, Jing‐wei Zhao, Jia‐yun Zhu, Cheng Zhao, Zi‐yi Yang, Li‐jia Pan, Ben Ma, Zheng‐yu Chen, Zi‐ying Wang, Chun‐jie Li, Shi‐lei Liu, Jia‐wei Mei, Ping Dong   +12 more
wiley   +1 more source

Ferroptosis in biliary tract cancer: Molecular mechanisms and therapeutic applications (Review). [PDF]

Int J Oncol
Zou R, Dai Y, Yang S, Hu H, Li F, Liu F.
europepmc   +1 more source

ESMO Clinical Practice Guideline interim update on the management of biliary tract cancer

ESMO Open
A. Vogel, M. Ducreux
semanticscholar   +1 more source

PEARL: Protein Eluting Alginate with Recombinant Lactobacilli

Small, EarlyView.
Probiotic lactobacilli meet engineered living materials: This study introduces PEARL (protein eluting alginate with recombinant lactobacilli), an innovative engineered living material combining Lactiplantibacillus plantarum and alginate beads for controlled protein release.
Varun Sai Tadimarri, Marc Blanch‐Asensio, Ketaki Deshpande, Jonas Baumann, Carole Baumann, Rolf Müller, Sara Trujillo, Shrikrishnan Sankaran   +7 more
wiley   +1 more source

Impact of ERCC1 on the outcomes of chemotherapy in advanced biliary tract cancer. [PDF]

Sci Rep
Sakamoto Y, Morizane C, Okusaka T, Mizusawa J, Hiraoka N, Shirota T, Ueno M, Kobayashi S, Ikeda M, Imaoka H, Ozaka M, Okano N, Yamaguchi H, Mizuno N, Nishina T, Katanuma A, Kojima Y, Gotoh K, Okamura K, Kawamoto Y, Sugimori K, Terashima T, Sugimoto R, Shirakawa H, Furuse J.   +24 more
europepmc   +1 more source

Bioengineered Bacterial Vesicles and Biomimetic Hybrids Eliminate Biofilms and Balance the Gut Microbiome

Small, EarlyView.
Biomimetic nanocarriers based on liposomes and Myxobacteria outer‐membrane vesicles (OMVs) are effective antibiotic delivery systems. Hybrids have a higher drug loading and can target intracellular pathogens, while OMVs evade immune clearance. Biomimetic nanoantibiotics effectively eliminate the biofilms of Gram‐negative bacteria. Besides, Myxobacteria
Leila Pourtalebi Jahromi, Benedikt Kronast, Jennifer Munkert, Lorenzo Sana, Marcus Koch, Heike Danzer, Sirka Dormeyer, Shuhan Jiang, Fabian Herrmann, Matthias Weiler, Anna Kashkanova, Vahid Sandoghdar, Mario M. Zaiss, Gregor Fuhrmann   +13 more
wiley   +1 more source

Predictors of overall survival in advanced biliary tract cancer in the phase 3 TOPAZ-1 study. [PDF]

Hepatol Commun
He AR, Bouattour M, Gupta VG, Evesque L, Zhen DB, Park JO, Sookprasert A, Salvatierra A, Vaccaro G, Oh SC, Ostoich SA, Satoh T, Kuzko A, Żotkiewicz M, Rokutanda N, Oh DY.   +15 more
europepmc   +1 more source

Advances in cholesterol and lipoproteins detection for healthcare: A review

VIEW, EarlyView.
Cholesterol is one of the main biomarkers related to the development of cardiovascular diseases. Its detection still relies on traditional methods of analysis, such as gas and liquid chromatographies. Detection of free cholesterol in saliva with redox or enzymatic sensors or detection of lipoproteins in blood with aptamer sensors are currently the most
Jacopo Giaretta, Somayeh Fardindoost, Azadeh Abdi, Kaveh Yazdani, Longfei Yin, Syamak Farajikhah, Mina Hoorfar, Fariba Dehghani   +7 more
wiley   +1 more source

Current insights and future perspectives of treatment strategies for biliary tract cancer. [PDF]

World J Gastrointest Oncol
Nakagawa K, Tsujinaka S, Katayose Y, Yambe K, Sakurai H, Takami K, Kondo N, Yamamoto K, Shibata C.   +8 more
europepmc   +1 more source